Innovative Peptide Manufacturing Methods That Scale
Presentation at NextGen Biomed 2026
Key Highlights
- Rising peptide demand, fueled by strong GLP-1 momentum, is driving the need for scalable production that supports commercial timelines
- Solid-phase peptide synthesis (SPPS) is essential, yet its waste intensity makes process efficiency and sustainability a key focus for CDMOs
- CPC Scientific’s Case Study: Our SPPS process innovations supported multi-kilo delivery of a pharmaceutically relevant polypeptide while reducing cost, environmental impact, and time to market
Timestamps
- 4:52 – Peptide Market Growth & Manufacturing Evolution
- 8:01 – CDMO Priorities & Case Study Overview
- 9:49 – Key Process Innovations
- 15:45 – Closing Insights
Interested in optimizing your SPPS process at scale?
Connect with our team to explore how strategic process design can enhance sustainability and delivery timelines for your peptide and oligo programs.
Construction begins on CPC Scientific’s 41,000 sq ft building in Rocklin to establish a new Center of Excellence for Peptide Manufacturing.
Join us as we celebrate a proud milestone: the successful listing of Medtide Inc., parent company of CPC Scientific, on the Hong Kong Stock Exchange!
Sheri Ambriz, MBA took the stage at TIDES USA 2025 in San Diego, CA, to share insights on green approaches to peptide and peptide–oligonucleotide conjugate manufacturing.
Gain insights from Joseph Denby's rapid-fire Q&A spotlight at NextGen Biomed 2025, where he explores the landscape of peptide and oligo APIs, as well as the role of green chemistry in manufacturing.
Watch Tim Nieters, MBA's presentation at TIDES USA 2024, where he covers process development & GMP manufacturing of DOTAGA-labeled peptide & POC-based products...
Backed by nearly 25 years of dedicated service to the pharmaceutical industry, CPC Scientific is a CRDMO specializing in synthetic peptide manufacturing for early-phase, late-phase development, and commercial production with metric-ton scale GMP API capacity...
We ensure the highest quality standards for late-stage and commercial API manufacturing, following comprehensive CGMP guidelines and testing protocols. We provide complete regulatory support for your IND and NDA filings in the USA and all international filings, ensuring global compliance...
CPC Scientific offers a variety of generic peptides used as active pharmaceutical ingredients. With our expertise in ANDA and NCE development, including DMF preparation, NDA submissions, and full regulatory support, we provide efficient and reliable pathways for API regulatory approval.
CPC Scientific combines cutting-edge technology with metric-ton scale API capacity, with annual production capacity of over 1000 kg and per-batch capacity of 20–25 kg. Our pre-qualified workspace allows us to initiate API production sooner than most peptide manufacturers...
We offer both research-grade and clinical-grade oligonucleotide manufacturing services. Using solid-phase synthesis, we provide custom oligo development, scale-up, and analytical testing, supporting clients across the entire lifecycle from early discovery through clinical stages...
As a leading GMP-compliant peptide and oligo manufacturer based in the USA, CPC Scientific treats each program as a true partnership. With our client-first project management approach, we provide complete lifecycle support at every stage, combining personalized project leadership with the seamless coordination needed to scale...
